About CAR T-REX

The CAR T-REX consortium was awarded a €2.7M Pathfinder Open Grant (No. 101099867) by the European Innovation Council (EIC) to develop novel, scalable CAR T cell therapies with increased efficacy for the treatment of solid tumours. The project started in June 2023 and will run for 4 years.

About EIC

The European Innovation Council (EIC) was created as part of the EU Horizon Europe program. With a €10.1 billion budget, it aims to support game-changing ideas from early-stage research to proof of concept, technology transfer, and the financing and scaling-up of start-ups and SMEs. The EIC Pathfinder Open provides funding for projects in any field of science or technology based on high-risk/high-gain science-towards-technology breakthrough interdisciplinary research.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.​

Follow CAR T-REX on Social Media